Filtered By:
Condition: Mitochondrial Disease
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 454 results found since Jan 2013.
The application of nucleic acid nanomaterials in the treatment of mitochondrial dysfunction
Curr Drug Metab. 2023 Jun 14. doi: 10.2174/1389200224666230614115655. Online ahead of print.ABSTRACTMitochondrial dysfunction is considered highly related to the development and progression of diseases, including cancer, metabolism disturbance, and neurodegeneration. Traditional pharmacological approach for mitochondrial dysfunction treatment has off-target and dose-dependent side effects, which leads to the emergence of mitochondrial gene therapy by regulating coding or noncoding genes by using nucleic acid sequences such as oligonucleotides, peptide nucleic acids, rRNA, siRNA, etc. To avoid size heterogeneity and potenti...
Source: Current Drug Metabolism - June 15, 2023 Category: Drugs & Pharmacology Authors: Lan Yao Hai Qing Tao Zhang Source Type: research
Cyclophilin D Contributes to Airway Epithelial Mitochondrial Damage in Chronic Obstructive Pulmonary Disease
ConclusionThese data suggest that CypD signaling pathway is involved in the pathogenesis of COPD and provide a potential therapeutic target for COPD.
Source: Lung - June 1, 2023 Category: Respiratory Medicine Source Type: research
Metformin protects against retinal ischemia/reperfusion injury through AMPK-mediated mitochondrial fusion
This study aims to evaluate the protective effect of metformin against retinal I/R injury and its underlying mechanism. I/R induced reduction in retina thickness and cell number in ganglion cell layer, and metformin alleviated I/R-induced retinal injury. Both retinal I/R and simulated ischemia/reperfusion (SIR) in R28 cells down-regulated expression of mitochondrial fusion protein Mfn2 and OPA1, which led to mitochondrial fission. Metformin also alleviated damage in R28 cells, and reversed the alteration in Mfn2 and OPA1, mitochondrial fission and mitochondrial membrane potential (MMP) disruption-induced by I/R or SIR as w...
Source: Free Radical Biology and Medicine - May 30, 2023 Category: Biology Authors: Kun Zhang Tao Wang Gui-Feng Sun Jin-Xing Xiao Li-Ping Jiang Fang-Fang Tou Xin-Hui Qu Xiao-Jian Han Source Type: research
Neuroprotective effects of the PPAR β/δ antagonist GSK0660 in in vitro and in vivo Parkinson's disease models
CONCLUSIONS: In summary, PPARβ/δ antagonist displayed neuroprotective activities against 6-hydroxydopamine detrimental effects both in vitro and in vivo models of Parkinson's disease, suggesting that it may represent a novel therapeutic approach for this disorder.PMID:37226204 | DOI:10.1186/s40659-023-00438-1
Source: Cell Research - May 24, 2023 Category: Cytology Authors: Andrea Antonosante Vanessa Castelli Martina Sette Margherita Alfonsetti Mariano Catanesi Elisabetta Benedetti Matteo Ardini Annamaria Cimini Michele d'Angelo Source Type: research
Neocryptotanshinone ameliorates insufficient energy production in heart failure by targeting retinoid X receptor alpha
In conclusion, we confirmed that NCTS improves myocardial energy metabolism, including fatty acid oxidation and mitochondrial biogenesis, by regulating the RXRα/PPARα pathway in mice with HF post-AMI.PMID:37201263 | DOI:10.1016/j.biopha.2023.114868
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - May 18, 2023 Category: Drugs & Pharmacology Authors: Lin Ma Mingyan Shao Wenkun Cheng Jinchi Jiang Xu Chen Nannan Tan Guanjing Ling Ye Yang Qian Wang Ran Yang Chun Li Yong Wang Source Type: research
Acrolein produced during acute kidney injury promotes tubular cell death
Biochem Biophys Res Commun. 2023 May 9;666:137-145. doi: 10.1016/j.bbrc.2023.05.029. Online ahead of print.ABSTRACTAcute kidney injury is an important global health concern as it is associated with high morbidity and mortality. Polyamines, essential for cell growth and proliferation, are known to inhibit cardiovascular disease. However, under conditions of cellular damage, toxic acrolein is produced from polyamines by the enzyme spermine oxidase (SMOX). We used a mouse renal ischemia-reperfusion model and human proximal tubule cells (HK-2) to investigate whether acrolein exacerbates acute kidney injury by renal tubular cel...
Source: Biochemical and Biophysical Research communications - May 15, 2023 Category: Biochemistry Authors: Seishi Aihara Kumiko Torisu Yutaro Hirashima Takanari Kitazono Toshiaki Nakano Source Type: research
ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response
CONCLUSIONS: ATF5 could exert a protective effect in a very early stage but promoted tubulointerstitial injury by regulating HSP60 and the UPRmt pathway under DKD conditions, providing a potential target for the prevention of DKD progression.PMID:37095454 | DOI:10.1186/s10020-023-00651-4
Source: Molecular Medicine - April 24, 2023 Category: Molecular Biology Authors: Yifei Liu Lei Zhang Shumin Zhang Jialu Liu Xiaohui Li Kexin Yang Danyi Yang Yu Liu Lin Sun Fuyou Liu Li Xiao Source Type: research
